Scott Huennekens - EndoChoice Holdings Chairman of the Board
Chairman
Mr. R. Scott Huennekens is Director of the company. Mr. Huennekens has served as President and Chief Executive Officer of Volcano Corporation a medical imaging company since April 2002. Previously he served as the President and Chief Executive Officer of Digirad Corporation a medical imaging company from 2000 to 2002. He originally joined Digirad as a startup in 1997 as Chief Operating Officer. From 1993 to 1997 he worked at Baxter International Inc. a global health care company with increasing responsibilities including as division Vice President of Sales and Marketing since 2016.
| Age | 50 |
| Tenure | 8 years |
| Professional Marks | MBA |
| Phone | 888-682-3636 |
| Web | http://www.endochoice.com |
EndoChoice Holdings Management Efficiency
The company has Return on Asset (ROA) of (0.473) % which means that for every 100 dollars spent on asset, it generated a loss of $0.473. This is way below average. EndoChoice Holdings' management efficiency ratios could be used to measure how well EndoChoice Holdings manages its routine affairs as well as how well it operates its assets and liabilities.The company reports 42.64 M of total liabilities with total debt to equity ratio (D/E) of 0.7, which is normal for its line of buisiness. EndoChoice Holdings has a current ratio of 5.52, indicating that it is in good position to pay out its debt commitments in time. Debt can assist EndoChoice Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, EndoChoice Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like EndoChoice Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for EndoChoice to invest in growth at high rates of return. When we think about EndoChoice Holdings' use of debt, we should always consider it together with cash and equity.
Similar Executives
| Found 4 records | CHAIRMAN Age | ||
| Kenneth Hicks | Academy Sports OutdoorsInc | 72 | |
| Stephen Spinelli | Planet Fitness | 66 | |
| Kenneth Brotman | Funko Inc | 52 | |
| David Netherway | Academy Sports OutdoorsInc | N/A | |
Management Performance
| Return On Asset | -0.47 |
EndoChoice Holdings Leadership Team
Elected by the shareholders, the EndoChoice Holdings' board of directors comprises two types of representatives: EndoChoice Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of EndoChoice. The board's role is to monitor EndoChoice Holdings' management team and ensure that shareholders' interests are well served. EndoChoice Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, EndoChoice Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simon MA, CFO | ||
| Scott Huennekens, Chairman of the Board | ||
| David Kaufman, Director | ||
| David Mowry, Director | ||
| Douglas Ladd, Chief Marketing Officer | ||
| Rurik Vandevenne, Director | ||
| Simon Tam, President CEO, Director | ||
| John Smyth, Director | ||
| James Balkcom, Director | ||
| Kevin Rubey, COO | ||
| Mark Gilreath, Founder, CEO and President and Director | ||
| Scott Davis, Director | ||
| Uri Geiger, Director | ||
| Scott Carter, Director | ||
| David Gill, CFO | ||
| Craig Walker, Director | ||
| William Enquist, Director | ||
| Michael Ballanger, Director | ||
| John Barr, Chairman of the Board, Interim CEO | ||
| Eric Schjelderup, Director |
EndoChoice Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is EndoChoice Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -0.47 | |||
| Profit Margin | (0.0001) % | |||
| Operating Margin | (0.0001) % | |||
| Current Valuation | 201.86 M | |||
| Shares Outstanding | 21.08 M | |||
| Shares Owned By Insiders | 13.73 % | |||
| Shares Owned By Institutions | 46.30 % | |||
| Number Of Shares Shorted | 349.75 K | |||
| Price To Earning | (2.96) X | |||
| Price To Book | 3.28 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards EndoChoice Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, EndoChoice Holdings' short interest history, or implied volatility extrapolated from EndoChoice Holdings options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in EndoChoice Stock
If you are still planning to invest in EndoChoice Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the EndoChoice Holdings' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |